Comprehensive Cancer Centers of Nevada ( Site 0010)

Las Vegas, Nevada 89169

2 studies enrolling now · 3 studies all time

What they study most

Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer Metastatic, Prostatic Neoplasms, Renal Cell Carcinoma

Studies at this site

• Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) — Recruiting now
• A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) — Recruiting now
• Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61) — Completed